Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer

This publication has 13 references indexed in Scilit:

• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer
  Cancer, 1995
• A Study of Oral Etoposide, Infusional Cisplatin, and Infusional 5-Fluorouracil for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
  American Journal of Clinical Oncology, 1992
• In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line
  Cancer Chemotherapy and Pharmacology, 1992
• Alternating sequential cisplatin (CDDP) and 5-fluorouracil (FU) in continuous infusion (CI) for advanced bronchogenic carcinoma
  Lung Cancer, 1991
• Fluorouracil: biochemistry and pharmacology.
  Journal of Clinical Oncology, 1988
• Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice
  Cancer Chemotherapy and Pharmacology, 1988
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
  Journal of Clinical Oncology, 1988
• Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
  Proceedings of the National Academy of Sciences, 1986
• Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay
  Cancer Chemotherapy and Pharmacology, 1985